Worth Venture Partners »

Sarepta Therapeutics shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $521k 5.4k 96.43
2023-09-30 $885k 7.3k 121.22

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics